Zhang, Run
Anguiano, Maribel
Aarrestad, Isak K.
Lin, Sophia
Chandra, Joshua
Vadde, Sruti S.
Olson, David E. https://orcid.org/0000-0002-4517-0543
Kim, Christina K. https://orcid.org/0000-0002-1466-7098
Funding for this research was provided by:
Brain and Behavior Research Foundation (NARSAD Young Investigator Grant #30238)
Kinship Foundation (Searle Scholars Program #SSP-2022-107)
Arnold and Mabel Beckman Foundation (Beckman Young Investigator Award)
U.S. Department of Health & Human Services | National Institutes of Health (DP2MH136588, T32 MH112507, R35GM148182)
National Science Foundation (NRT NeuralStorm #2152260, GRFP #000895154)
Boone Family Foundation
Article History
Received: 11 July 2023
Accepted: 21 June 2024
First Online: 5 August 2024
Competing interests
: D.E.O. is a cofounder of Delix Therapeutics and serves as the chief innovation officer and head of the scientific advisory board. The other authors declare no competing interests.